Thus, we conducted a network meta-analysis of real population-based cohort studies to investigate and compare the effects and relationship between SGLT-2i, GLP-1 RAs, and DPP-4i on bone fracture risk in patients with T2DM in the real world. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.